Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuso Takeda

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|October 4, 2013
[Medicinal chemistry and pharmacology focused on cannabidiol, a major component of the fiber-type cannabis]Shuso Takeda
Biological & Pharmaceutical Bulletin|September 2, 2014
Δ9-Tetrahydrocannabinol targeting estrogen receptor signaling: the possible mechanism of action coupled with endocrine disruptionShuso Takeda
Drug Metabolism Reviews|October 13, 2009
Modulation of UDP-glucuronosyltransferase activity by protein-protein associationYuji Ishii, Shuso Takeda, Hideyuki Yamada
Toxicology|May 12, 2009
Modulation of Delta9-tetrahydrocannabinol-induced MCF-7 breast cancer cell growth by cyclooxygenase and aromataseShuso Takeda, Ikuo Yamamoto, Kazuhito Watanabe
Biochemical and Biophysical Research Communications|May 2, 2026
Antiproliferative effects of TUBB3 in ERα-positive postmenopausal breast cancer model cellsMasayo Hirao-Suzuki, Koki Kanameda, Shuso Takeda
Toxicology Letters|January 12, 2026
Cadmium interferes with the antiproliferative effect of fulvestrant in endocrine therapy-resistant estrogen receptor α-positive breast cancer cellsKoki Kanameda, Masayo Hirao-Suzuki, Shuso Takeda
Frontiers in Bioscience : a Journal and Virtual Library|December 1, 2004
Functional protein-protein interaction of drug metabolizing enzymesYuji Ishii, Shuso Takeda, Hideyuki Yamada, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 2, 2009
Cannabidiol-2',6'-dimethyl ether, a cannabidiol derivative, is a highly potent and selective 15-lipoxygenase inhibitorShuso Takeda, Noriyuki Usami, Ikuo Yamamoto, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 17, 2008
Cannabidiolic acid as a selective cyclooxygenase-2 inhibitory component in cannabisShuso Takeda, Koichiro Misawa, Ikuo Yamamoto, et al.
Toxicology Letters|March 2, 2023
Repeated exposure to 4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP) accelerates ligand-independent activation of estrogen receptors in long-term estradiol-deprived MCF-7 cellsMasayo Hirao-Suzuki, Masufumi Takiguchi, Shin'ichi Yoshihara, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|October 4, 2013
[Medicinal chemistry and pharmacology focused on cannabidiol, a major component of the fiber-type cannabis]Shuso Takeda
Biological & Pharmaceutical Bulletin|September 2, 2014
Δ9-Tetrahydrocannabinol targeting estrogen receptor signaling: the possible mechanism of action coupled with endocrine disruptionShuso Takeda
Drug Metabolism Reviews|October 13, 2009
Modulation of UDP-glucuronosyltransferase activity by protein-protein associationYuji Ishii, Shuso Takeda, Hideyuki Yamada
Toxicology|May 12, 2009
Modulation of Delta9-tetrahydrocannabinol-induced MCF-7 breast cancer cell growth by cyclooxygenase and aromataseShuso Takeda, Ikuo Yamamoto, Kazuhito Watanabe
Biochemical and Biophysical Research Communications|May 2, 2026
Antiproliferative effects of TUBB3 in ERα-positive postmenopausal breast cancer model cellsMasayo Hirao-Suzuki, Koki Kanameda, Shuso Takeda
Toxicology Letters|January 12, 2026
Cadmium interferes with the antiproliferative effect of fulvestrant in endocrine therapy-resistant estrogen receptor α-positive breast cancer cellsKoki Kanameda, Masayo Hirao-Suzuki, Shuso Takeda
Frontiers in Bioscience : a Journal and Virtual Library|December 1, 2004
Functional protein-protein interaction of drug metabolizing enzymesYuji Ishii, Shuso Takeda, Hideyuki Yamada, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 2, 2009
Cannabidiol-2',6'-dimethyl ether, a cannabidiol derivative, is a highly potent and selective 15-lipoxygenase inhibitorShuso Takeda, Noriyuki Usami, Ikuo Yamamoto, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 17, 2008
Cannabidiolic acid as a selective cyclooxygenase-2 inhibitory component in cannabisShuso Takeda, Koichiro Misawa, Ikuo Yamamoto, et al.
Toxicology Letters|March 2, 2023
Repeated exposure to 4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP) accelerates ligand-independent activation of estrogen receptors in long-term estradiol-deprived MCF-7 cellsMasayo Hirao-Suzuki, Masufumi Takiguchi, Shin'ichi Yoshihara, et al.
Pageof 7